This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Jiuzhitang Co., Ltd., Mudanjiang Youbo Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Zhiyuan Nan: Innovator in Antithrombotic Research
Introduction
Zhiyuan Nan is a notable inventor based in Mudanjiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit coagulation factors. His work is essential for advancing treatments for thrombotic diseases.
Latest Patents
Zhiyuan Nan holds a patent for an "Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof." This patent describes a purified oligosaccharide compound that exhibits antithrombotic activity. It includes a preparation method for the compound and its pharmaceutical applications as an intrinsic factor X-enzyme inhibitor, which is crucial for developing drugs aimed at preventing and treating thrombotic diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Zhiyuan Nan has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Jiuzhitang Co., Ltd. and Mudanjiang Youbo Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to contribute to significant advancements in drug development.
Collaborations
Zhiyuan Nan has collaborated with several professionals in his field, including Longyan Zhao and Yanming Chen. These partnerships have facilitated the exchange of ideas and expertise, further enhancing his research and innovations.
Conclusion
Zhiyuan Nan's work in the development of antithrombotic compounds showcases his dedication to improving healthcare solutions. His innovative contributions are vital for the ongoing fight against thrombotic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile